Dea Garic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dea Garic has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
- Mark D. Shen
University of North Carolina at Chapel Hill
6 shared publications - Annette Estes
Department of Speech and Hearing Sciences University of Washington Seattle Washington USA
4 shared publications - Heather Cody Hazlett
University of North Carolina at Chapel Hill
4 shared publications - Jason J. Wolff
University of Minnesota
4 shared publications - Joseph Piven
University of North Carolina at Chapel Hill
4 shared publications - Martin Styner
University of North Carolina at Chapel Hill
4 shared publications
Latest Publications
- Open Access
Assessment of adaptive functioning in Angelman syndrome using the Vineland Adaptive Behavior Scales, Third Edition
Purpose: This study examined longitudinal trajectories of adaptive functioning in 331 individuals with Angelman syndrome (AS) using the Vineland Adaptive Behavior Scales, Third Edition (Vineland-3) and examined differences by molecular subtype. Methods: A total of 331 individuals (156 females, 47%) with genetically confirmed AS (ages 6 months to 52 years) were assessed between 2018 and 2025, including 207 with a deletion subtype, 63 with uniparental disomy or imprinting defect, and 61 with a UBE3A point mutation. Growth scale values were analyzed using linear mixed-effects models with log 2 -transformed age. Results: Individuals with deletion subtypes demonstrated significantly lower adaptive functioning across domains compared to those with non-deletion subtypes. Adaptive skills across all Vineland-3 subdomains increased nonlinearly with age, showing faster growth early in life that slowed over time, with largely parallel trajectories across subtypes. Conclusion: Individuals with AS demonstrate slow but steady growth in adaptive functioning that continues into adulthood, with progress varying by molecular subtype. These findings provide updated natural history benchmarks and demonstrate the utility of the Vineland-3 for clinical trials.
Open AccessAssessment of adaptive functioning in Angelman syndrome using the Vineland Adaptive Behavior Scales, Third Edition
Purpose: This study examined longitudinal trajectories of adaptive functioning in 331 individuals with Angelman syndrome (AS) using the Vineland Adaptive Behavior Scales, Third Edition (Vineland-3) and examined differences by molecular subtype. Methods: A total of 331 individuals (156 females, 47%) with genetically confirmed AS (ages 6 months to 52 years) were assessed between 2018 and 2025, including 207 with a deletion subtype, 63 with uniparental disomy or imprinting defect, and 61 with a UBE3A point mutation. Growth scale values were analyzed using linear mixed-effects models with log 2 -transformed age. Results: Individuals with deletion subtypes demonstrated significantly lower adaptive functioning across domains compared to those with non-deletion subtypes. Adaptive skills across all Vineland-3 subdomains increased nonlinearly with age, showing faster growth early in life that slowed over time, with largely parallel trajectories across subtypes. Conclusion: Individuals with AS demonstrate slow but steady growth in adaptive functioning that continues into adulthood, with progress varying by molecular subtype. These findings provide updated natural history benchmarks and demonstrate the utility of the Vineland-3 for clinical trials.
- Open Access
Variation in infant subcortical brain development from 6 to 12 months in Down syndrome
Introduction: Down syndrome (DS), arising from Trisomy 21, is the most common genetic condition associated with intellectual disability. While smaller total brain volumes have been consistently observed in DS, no longitudinal neuroimaging studies have examined volumetric brain development in DS during infancy, a period of rapid neural growth when interventions may have the greatest impact. Method: High-resolution T1- and T2-weighted images were acquired during natural sleep in a multisite longitudinal cohort of 44 infants with DS and 39 control infants without DS at ages 6 and 12 months. Neuroimaging data were harmonized to reduce batch effects, and a novel deep-learning, repeated-measures segmentation approach was applied to optimize neuroanatomical segmentations. Total intracranial volume (ICV) and bilateral absolute subcortical volumes (amygdala, caudate, hippocampus, pallidum, putamen, thalamus) were first directly compared in infants with and without DS at 6 and 12 months. Hierarchical linear modeling (HLM) evaluated longitudinal group differences for each structure, accounting for sex, gestational age, and laterality. Subcortical group differences estimated by HLM were also compared to group differences in total ICV. Results: ICV in infants with DS was lower than controls at 6 months (12.6%; p< .001) and 12 months (16.3%; p< .001). Subcortical structures displayed a range of lower volumes (6.9%-13.1%; p’s ≤.003) in infants with DS, although the caudate and putamen were exceptions. Caudate volumes were on average lower in DS but not significantly different from controls, while putamen volumes were on average higher in DS but not significantly different from controls, except for the right putamen, which was significantly larger (5.3%; p =.018) at 6 months. In HLM, ICV and all subcortical structures showed slower growth in DS from 6 to 12 months, except for the amygdala and putamen, which displayed similar growth rates to controls. DS-associated reductions in subcortical volumes were similar in magnitude to ICV, although 12-month caudate and 6- and 12-month putamen volumes were enlarged relative to ICV. Conclusion: Infants with DS exhibited substantially reduced ICV and widespread reductions in subcortical volumes and growth from 6-12 months. Across a range of volumetric differences, findings were most distinct in the basal ganglia, for which volume reductions were attenuated in the caudate, while the putamen was uniquely enlarged with comparable growth to controls. These observations support early regional specificity in the neural impact of Trisomy 21 and underscore the utility of infant neuroimaging to inform biologically based interventions and clinical trial readiness in DS.
Open AccessVariation in infant subcortical brain development from 6 to 12 months in Down syndrome
Introduction: Down syndrome (DS), arising from Trisomy 21, is the most common genetic condition associated with intellectual disability. While smaller total brain volumes have been consistently observed in DS, no longitudinal neuroimaging studies have examined volumetric brain development in DS during infancy, a period of rapid neural growth when interventions may have the greatest impact. Method: High-resolution T1- and T2-weighted images were acquired during natural sleep in a multisite longitudinal cohort of 44 infants with DS and 39 control infants without DS at ages 6 and 12 months. Neuroimaging data were harmonized to reduce batch effects, and a novel deep-learning, repeated-measures segmentation approach was applied to optimize neuroanatomical segmentations. Total intracranial volume (ICV) and bilateral absolute subcortical volumes (amygdala, caudate, hippocampus, pallidum, putamen, thalamus) were first directly compared in infants with and without DS at 6 and 12 months. Hierarchical linear modeling (HLM) evaluated longitudinal group differences for each structure, accounting for sex, gestational age, and laterality. Subcortical group differences estimated by HLM were also compared to group differences in total ICV. Results: ICV in infants with DS was lower than controls at 6 months (12.6%; p< .001) and 12 months (16.3%; p< .001). Subcortical structures displayed a range of lower volumes (6.9%-13.1%; p’s ≤.003) in infants with DS, although the caudate and putamen were exceptions. Caudate volumes were on average lower in DS but not significantly different from controls, while putamen volumes were on average higher in DS but not significantly different from controls, except for the right putamen, which was significantly larger (5.3%; p =.018) at 6 months. In HLM, ICV and all subcortical structures showed slower growth in DS from 6 to 12 months, except for the amygdala and putamen, which displayed similar growth rates to controls. DS-associated reductions in subcortical volumes were similar in magnitude to ICV, although 12-month caudate and 6- and 12-month putamen volumes were enlarged relative to ICV. Conclusion: Infants with DS exhibited substantially reduced ICV and widespread reductions in subcortical volumes and growth from 6-12 months. Across a range of volumetric differences, findings were most distinct in the basal ganglia, for which volume reductions were attenuated in the caudate, while the putamen was uniquely enlarged with comparable growth to controls. These observations support early regional specificity in the neural impact of Trisomy 21 and underscore the utility of infant neuroimaging to inform biologically based interventions and clinical trial readiness in DS.
- Open Access
- 16 January 2026
- Published by Springer Nature in Journal of Neurodevelopmental Disorders
- Vol. 18 (1)
Extra-axial cerebrospinal fluid volumes from 6 to 24 months of age are associated with poorer executive function at school-age in children with and without autism
Background: Abnormally increased extra-axial cerebrospinal fluid (EA-CSF) volume is present as early as 6 months in infants later diagnosed with autism and is associated with symptom severity at the age of diagnosis, but it is unknown whether early EA-CSF enlargement has long-term impacts on other clinical domains. Executive function (EF) deficits are frequently observed in children with autism and are linked with worse academic outcomes, higher anxiety, and lower adaptive functioning. The current study examines the association between EA-CSF volume at infancy and EF at school age in a longitudinally phenotyped cohort of children with either high (HL) or low (LL) familial likelihood for autism. Methods: In this prospective study, 239 infants underwent MRI scans during natural sleep at 6, 12, and 24 months of age. HL was defined as having an older sibling with autism. The sample was divided into three diagnostic groups: HL infants who were diagnosed with autism at 24 months (HL+, n = 34), HL infants not diagnosed with autism (HL-, n = 131), and LL infants without autism (LL-, n = 74). Two parent-rating scales of EF were collected at the school-age follow-up ( M age = 10.4 years ± 1.34): the Behavior Rating Inventory of Executive Function (BRIEF) and Conners Parent Short Form. ANOVA was used to test for diagnostic group differences in EF. Longitudinal mixed-effects models utilized EA-CSF volumes in infancy to predict EF at school-age, while controlling for IQ, sex, total cerebral volume, and diagnostic group. Results: Consistent with previous literature, HL + participants had greater EF deficits than both HL- and LL- on the BRIEF ( F = 18.46, p < .0001) and greater EF deficits than LL- on the Conners ( F = 8.55, p < .001). Further, higher EA-CSF volumes during infancy were associated with poorer executive function eight years later on both BRIEF ( ß =0.18, p < .001) and Conners ( ß =0.18, p < .001). This association between EA-CSF and executive function was observed across familial likelihood and diagnostic groups. Conclusions: Our study indicates that elevations in EA-CSF volumes during infancy, even in those who do not have autism, have long-term associations beyond autism symptomatology. These findings underscore the potential link between infant CSF physiology and future behavioral domains such as executive function at school age.
- 16 January 2026
- Published by Springer Nature in Journal of Neurodevelopmental Disorders
- Vol. 18 (1)
Open AccessExtra-axial cerebrospinal fluid volumes from 6 to 24 months of age are associated with poorer executive function at school-age in children with and without autism
Background: Abnormally increased extra-axial cerebrospinal fluid (EA-CSF) volume is present as early as 6 months in infants later diagnosed with autism and is associated with symptom severity at the age of diagnosis, but it is unknown whether early EA-CSF enlargement has long-term impacts on other clinical domains. Executive function (EF) deficits are frequently observed in children with autism and are linked with worse academic outcomes, higher anxiety, and lower adaptive functioning. The current study examines the association between EA-CSF volume at infancy and EF at school age in a longitudinally phenotyped cohort of children with either high (HL) or low (LL) familial likelihood for autism. Methods: In this prospective study, 239 infants underwent MRI scans during natural sleep at 6, 12, and 24 months of age. HL was defined as having an older sibling with autism. The sample was divided into three diagnostic groups: HL infants who were diagnosed with autism at 24 months (HL+, n = 34), HL infants not diagnosed with autism (HL-, n = 131), and LL infants without autism (LL-, n = 74). Two parent-rating scales of EF were collected at the school-age follow-up ( M age = 10.4 years ± 1.34): the Behavior Rating Inventory of Executive Function (BRIEF) and Conners Parent Short Form. ANOVA was used to test for diagnostic group differences in EF. Longitudinal mixed-effects models utilized EA-CSF volumes in infancy to predict EF at school-age, while controlling for IQ, sex, total cerebral volume, and diagnostic group. Results: Consistent with previous literature, HL + participants had greater EF deficits than both HL- and LL- on the BRIEF ( F = 18.46, p < .0001) and greater EF deficits than LL- on the Conners ( F = 8.55, p < .001). Further, higher EA-CSF volumes during infancy were associated with poorer executive function eight years later on both BRIEF ( ß =0.18, p < .001) and Conners ( ß =0.18, p < .001). This association between EA-CSF and executive function was observed across familial likelihood and diagnostic groups. Conclusions: Our study indicates that elevations in EA-CSF volumes during infancy, even in those who do not have autism, have long-term associations beyond autism symptomatology. These findings underscore the potential link between infant CSF physiology and future behavioral domains such as executive function at school age.
- Open Access
- 1 October 2025
- Published by Elsevier in NeuroImage
- Vol. 321, 121489
Early White Matter Microstructure Alterations in Infants with Down Syndrome
- 1 October 2025
- Published by Elsevier in NeuroImage
- Vol. 321, 121489
Open AccessEarly White Matter Microstructure Alterations in Infants with Down Syndrome
- Open Access
- 30 July 2025
- Published by Wiley in Annals of the Child Neurology Society
- Vol. 3 (3) , 165-175
Increased Extra‐Axial Cerebrospinal Fluid Volume in Children With Angelman Syndrome: Links to Sleep Problems and Seizures
Background: Previous studies demonstrated that children with autism have enlarged volumes of extra‐axial cerebrospinal fluid (EA‐CSF) and an increased ratio of EA‐CSF to brain volume, indicating that EA‐CSF is disproportionally increased beyond macrocephaly often observed in autism. It is unknown whether EA‐CSF is disproportionally enlarged in Angelman syndrome (AS), which shares phenotypic features with autism (sleep problems, seizures) but is characterized by microcephaly. This study examined EA‐CSF and total cerebral volume (TCV) in AS children compared with neurotypical (NT) controls to test whether EA‐CSF is disproportionally enlarged and is associated with sleep problems and seizures.Methods: Magnetic resonance imaging scans were acquired in n = 29 AS (M[SD] = 6.95 ± 2.83 years) and n = 27 NT children (M[SD] = 7.96 ± 2.24). EA‐CSF and TCV were compared using analysis of covariance (ANCOVA), controlling for age, sex, and group interactions. In AS, associations between EA‐CSF, sleep quality, and seizure severity were evaluated by linear regression.Results: Children with AS had 22% smaller TCV (p < 0.0001) yet nearly identical EA‐CSF volumes (p = 0.35). The ratio of EA‐CSF to TCV was 48% higher in AS (p < 0.0001). Increased EA‐CSF ratio in AS was associated with sleep initiation problems (p = 0.002) and seizure severity (p = 0.032).Conclusion: Children with AS have disproportionally higher EA‐CSF volume than would be predicted by their smaller brain size. EA‐CSF was associated with sleep problems and seizures, which impact quality of life and are target endpoints of current AS clinical trials. Excessive CSF suggests that CSF circulation might be perturbed in AS, which could have implications for brain waste clearance and impact the biodistribution of AS therapies delivered via CSF.
- 30 July 2025
- Published by Wiley in Annals of the Child Neurology Society
- Vol. 3 (3) , 165-175
Open AccessIncreased Extra‐Axial Cerebrospinal Fluid Volume in Children With Angelman Syndrome: Links to Sleep Problems and Seizures
Background: Previous studies demonstrated that children with autism have enlarged volumes of extra‐axial cerebrospinal fluid (EA‐CSF) and an increased ratio of EA‐CSF to brain volume, indicating that EA‐CSF is disproportionally increased beyond macrocephaly often observed in autism. It is unknown whether EA‐CSF is disproportionally enlarged in Angelman syndrome (AS), which shares phenotypic features with autism (sleep problems, seizures) but is characterized by microcephaly. This study examined EA‐CSF and total cerebral volume (TCV) in AS children compared with neurotypical (NT) controls to test whether EA‐CSF is disproportionally enlarged and is associated with sleep problems and seizures.Methods: Magnetic resonance imaging scans were acquired in n = 29 AS (M[SD] = 6.95 ± 2.83 years) and n = 27 NT children (M[SD] = 7.96 ± 2.24). EA‐CSF and TCV were compared using analysis of covariance (ANCOVA), controlling for age, sex, and group interactions. In AS, associations between EA‐CSF, sleep quality, and seizure severity were evaluated by linear regression.Results: Children with AS had 22% smaller TCV (p < 0.0001) yet nearly identical EA‐CSF volumes (p = 0.35). The ratio of EA‐CSF to TCV was 48% higher in AS (p < 0.0001). Increased EA‐CSF ratio in AS was associated with sleep initiation problems (p = 0.002) and seizure severity (p = 0.032).Conclusion: Children with AS have disproportionally higher EA‐CSF volume than would be predicted by their smaller brain size. EA‐CSF was associated with sleep problems and seizures, which impact quality of life and are target endpoints of current AS clinical trials. Excessive CSF suggests that CSF circulation might be perturbed in AS, which could have implications for brain waste clearance and impact the biodistribution of AS therapies delivered via CSF.
- Open Access
- 18 June 2025
- Published by MIT Press in Neurobiology of Language
- Vol. 6
Structural Development of Speech Networks in Young Children: A Cross-Sectional Study
To investigate speech in the developing brain, 94 children aged 4 to 7 years old were scanned using diffusion weighted imaging (DWI) magnetic resonance imaging. To increase sample size and performance variability, we included children with ADHD from a larger ongoing study (n = 47). Each child completed the Syllable Repetition Task (SRT), a validated measure of phoneme articulation. DWI data were modeled using restriction spectrum imaging to measure restricted and hindered diffusion properties in gray and white matter. We analyzed the diffusion data using whole brain analysis and automated fiber quantification (AFQ) analysis to establish tract profiles for the six fiber pathways thought to be important for supporting speech development. In the whole brain analysis, we found that SRT performance was associated with restricted diffusion in left and right inferior frontal gyrus, left and right pars opercularis, right pre-supplementary and supplementary motor area, and left and right cerebellar gray matter (p < 0.005). Age moderated these associations in left pars opercularis and the frontal aslant tract (FAT), but only the cerebellar findings survived a cluster correction. Analyses using AFQ highlighted differences in high and low performing children along specific tract profiles, most notably in left but not right FAT, in left and right superior longitudinal fasciculus III, and in the cerebellar peduncles. These findings suggest that individual differences in speech performance are reflected in structural gray and white matter differences as measured by restricted and hindered diffusion metrics, and offer important insights into developing brain networks supporting speech in very young children.
- 18 June 2025
- Published by MIT Press in Neurobiology of Language
- Vol. 6
Open AccessStructural Development of Speech Networks in Young Children: A Cross-Sectional Study
To investigate speech in the developing brain, 94 children aged 4 to 7 years old were scanned using diffusion weighted imaging (DWI) magnetic resonance imaging. To increase sample size and performance variability, we included children with ADHD from a larger ongoing study (n = 47). Each child completed the Syllable Repetition Task (SRT), a validated measure of phoneme articulation. DWI data were modeled using restriction spectrum imaging to measure restricted and hindered diffusion properties in gray and white matter. We analyzed the diffusion data using whole brain analysis and automated fiber quantification (AFQ) analysis to establish tract profiles for the six fiber pathways thought to be important for supporting speech development. In the whole brain analysis, we found that SRT performance was associated with restricted diffusion in left and right inferior frontal gyrus, left and right pars opercularis, right pre-supplementary and supplementary motor area, and left and right cerebellar gray matter (p < 0.005). Age moderated these associations in left pars opercularis and the frontal aslant tract (FAT), but only the cerebellar findings survived a cluster correction. Analyses using AFQ highlighted differences in high and low performing children along specific tract profiles, most notably in left but not right FAT, in left and right superior longitudinal fasciculus III, and in the cerebellar peduncles. These findings suggest that individual differences in speech performance are reflected in structural gray and white matter differences as measured by restricted and hindered diffusion metrics, and offer important insights into developing brain networks supporting speech in very young children.
- Open Access
- 1 March 2025
- Published by Elsevier in Developmental Cognitive Neuroscience
- Vol. 73, 101540
White matter microstructure in school-age children with down syndrome
- 1 March 2025
- Published by Elsevier in Developmental Cognitive Neuroscience
- Vol. 73, 101540
Open AccessWhite matter microstructure in school-age children with down syndrome
- Open Access
Early White Matter Microstructure Alterations in Infants with Down Syndrome
Importance Down syndrome, resulting from trisomy 21, is the most prevalent chromosomal disorder and a leading cause of intellectual disability. Despite its significant impact on brain development, research on the white matter microstructure in infants with Down syndrome remains limited. Objective To investigate early white matter microstructure in infants with Down syndrome using diffusion tensor imaging (DTI) and neurite orientation dispersion and density imaging (NODDI). Design Infants were recruited and scanned between March 2019 and May 2024 as participants in prospective studies conducted by the Infant Brain Imaging Study (IBIS) Network. Data were analyzed in October 2024. Setting Data collection occurred at five research centers in Minnesota, Missouri, North Carolina, Pennsylvania, and Washington. Participants Down syndrome and control infants were scanned at 6 months of age. Control infants had no Down syndrome diagnosis and either had a typically developing older sibling or, if they had an older sibling with autism, were confirmed not to meet clinical best estimate criteria for an autism diagnosis. Exposure Diagnosis of Down syndrome. Main Outcomes and Measures The outcome of interest was white matter microstructure quantified using DTI and NODDI measures. Results A total of 49 Down syndrome (28 [57.14%] female) and 37 control (18 [48.65%] female) infants were included. Infants with Down syndrome showed significant reductions in fractional anisotropy and neurite density index across multiple association tracts, particularly in the inferior fronto-occipital fasciculus and superior longitudinal fasciculus II, consistent with reduced structural integrity and neurite density. These tracts also demonstrated increased radial diffusivity, suggesting delayed myelination. The inferior fronto-occipital fasciculus and uncinate fasciculus exhibited increased neurite dispersion and fanning in Down syndrome infants, reflected by elevated orientation dispersion index. Notably, the optic tracts in Down syndrome infants exhibited a distinct pattern of elevated fractional anisotropy and axial diffusivity, and lower radial diffusivity and orientation dispersion index, suggesting an early maturation of these pathways. Conclusions and Relevance This first characterization of white matter microstructure in Down syndrome infants reveals widespread white matter developmental delays. These findings provide new insights into the early neurodevelopment of Down syndrome and may inform early therapeutic interventions.
Open AccessEarly White Matter Microstructure Alterations in Infants with Down Syndrome
Importance Down syndrome, resulting from trisomy 21, is the most prevalent chromosomal disorder and a leading cause of intellectual disability. Despite its significant impact on brain development, research on the white matter microstructure in infants with Down syndrome remains limited. Objective To investigate early white matter microstructure in infants with Down syndrome using diffusion tensor imaging (DTI) and neurite orientation dispersion and density imaging (NODDI). Design Infants were recruited and scanned between March 2019 and May 2024 as participants in prospective studies conducted by the Infant Brain Imaging Study (IBIS) Network. Data were analyzed in October 2024. Setting Data collection occurred at five research centers in Minnesota, Missouri, North Carolina, Pennsylvania, and Washington. Participants Down syndrome and control infants were scanned at 6 months of age. Control infants had no Down syndrome diagnosis and either had a typically developing older sibling or, if they had an older sibling with autism, were confirmed not to meet clinical best estimate criteria for an autism diagnosis. Exposure Diagnosis of Down syndrome. Main Outcomes and Measures The outcome of interest was white matter microstructure quantified using DTI and NODDI measures. Results A total of 49 Down syndrome (28 [57.14%] female) and 37 control (18 [48.65%] female) infants were included. Infants with Down syndrome showed significant reductions in fractional anisotropy and neurite density index across multiple association tracts, particularly in the inferior fronto-occipital fasciculus and superior longitudinal fasciculus II, consistent with reduced structural integrity and neurite density. These tracts also demonstrated increased radial diffusivity, suggesting delayed myelination. The inferior fronto-occipital fasciculus and uncinate fasciculus exhibited increased neurite dispersion and fanning in Down syndrome infants, reflected by elevated orientation dispersion index. Notably, the optic tracts in Down syndrome infants exhibited a distinct pattern of elevated fractional anisotropy and axial diffusivity, and lower radial diffusivity and orientation dispersion index, suggesting an early maturation of these pathways. Conclusions and Relevance This first characterization of white matter microstructure in Down syndrome infants reveals widespread white matter developmental delays. These findings provide new insights into the early neurodevelopment of Down syndrome and may inform early therapeutic interventions.
- Open Access
- 1 December 2023
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 6 (12) , e2348341
Enlarged Perivascular Spaces in Infancy and Autism Diagnosis, Cerebrospinal Fluid Volume, and Later Sleep Problems
Importance: Perivascular spaces (PVS) and cerebrospinal fluid (CSF) are essential components of the glymphatic system, regulating brain homeostasis and clearing neural waste throughout the lifespan. Enlarged PVS have been implicated in neurological disorders and sleep problems in adults, and excessive CSF volume has been reported in infants who develop autism. Enlarged PVS have not been sufficiently studied longitudinally in infancy or in relation to autism outcomes or CSF volume.Objective: To examine whether enlarged PVS are more prevalent in infants who develop autism compared with controls and whether they are associated with trajectories of extra-axial CSF volume (EA-CSF) and sleep problems in later childhood.Design, Setting, and Participants: This prospective, longitudinal cohort study used data from the Infant Brain Imaging Study. Magnetic resonance images were acquired at ages 6, 12, and 24 months (2007-2017), with sleep questionnaires performed between ages 7 and 12 years (starting in 2018). Data were collected at 4 sites in North Carolina, Missouri, Pennsylvania, and Washington. Data were analyzed from March 2021 through August 2022.Exposure: PVS (ie, fluid-filled channels that surround blood vessels in the brain) that are enlarged (ie, visible on magnetic resonance imaging).Main Outcomes and Measures: Outcomes of interest were enlarged PVS and EA-CSF volume from 6 to 24 months, autism diagnosis at 24 months, sleep problems between ages 7 and 12 years.Results: A total of 311 infants (197 [63.3%] male) were included: 47 infants at high familial likelihood for autism (ie, having an older sibling with autism) who were diagnosed with autism at age 24 months, 180 high likelihood infants not diagnosed with autism, and 84 low likelihood control infants not diagnosed with autism. Sleep measures at school-age were available for 109 participants. Of infants who developed autism, 21 (44.7%) had enlarged PVS at 24 months compared with 48 infants (26.7%) in the high likelihood but no autism diagnosis group (P = .02) and 22 infants in the control group (26.2%) (P = .03). Across all groups, enlarged PVS at 24 months was associated with greater EA-CSF volume from ages 6 to 24 months (β = 4.64; 95% CI, 0.58-8.72; P = .002) and more frequent night wakings at school-age (F = 7.76; η2 = 0.08; P = .006).Conclusions and Relevance: These findings suggest that enlarged PVS emerged between ages 12 and 24 months in infants who developed autism. These results add to a growing body of evidence that, along with excessive CSF volume and sleep dysfunction, the glymphatic system could be dysregulated in infants who develop autism.
- 1 December 2023
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 6 (12) , e2348341
Open AccessEnlarged Perivascular Spaces in Infancy and Autism Diagnosis, Cerebrospinal Fluid Volume, and Later Sleep Problems
Importance: Perivascular spaces (PVS) and cerebrospinal fluid (CSF) are essential components of the glymphatic system, regulating brain homeostasis and clearing neural waste throughout the lifespan. Enlarged PVS have been implicated in neurological disorders and sleep problems in adults, and excessive CSF volume has been reported in infants who develop autism. Enlarged PVS have not been sufficiently studied longitudinally in infancy or in relation to autism outcomes or CSF volume.Objective: To examine whether enlarged PVS are more prevalent in infants who develop autism compared with controls and whether they are associated with trajectories of extra-axial CSF volume (EA-CSF) and sleep problems in later childhood.Design, Setting, and Participants: This prospective, longitudinal cohort study used data from the Infant Brain Imaging Study. Magnetic resonance images were acquired at ages 6, 12, and 24 months (2007-2017), with sleep questionnaires performed between ages 7 and 12 years (starting in 2018). Data were collected at 4 sites in North Carolina, Missouri, Pennsylvania, and Washington. Data were analyzed from March 2021 through August 2022.Exposure: PVS (ie, fluid-filled channels that surround blood vessels in the brain) that are enlarged (ie, visible on magnetic resonance imaging).Main Outcomes and Measures: Outcomes of interest were enlarged PVS and EA-CSF volume from 6 to 24 months, autism diagnosis at 24 months, sleep problems between ages 7 and 12 years.Results: A total of 311 infants (197 [63.3%] male) were included: 47 infants at high familial likelihood for autism (ie, having an older sibling with autism) who were diagnosed with autism at age 24 months, 180 high likelihood infants not diagnosed with autism, and 84 low likelihood control infants not diagnosed with autism. Sleep measures at school-age were available for 109 participants. Of infants who developed autism, 21 (44.7%) had enlarged PVS at 24 months compared with 48 infants (26.7%) in the high likelihood but no autism diagnosis group (P = .02) and 22 infants in the control group (26.2%) (P = .03). Across all groups, enlarged PVS at 24 months was associated with greater EA-CSF volume from ages 6 to 24 months (β = 4.64; 95% CI, 0.58-8.72; P = .002) and more frequent night wakings at school-age (F = 7.76; η2 = 0.08; P = .006).Conclusions and Relevance: These findings suggest that enlarged PVS emerged between ages 12 and 24 months in infants who developed autism. These results add to a growing body of evidence that, along with excessive CSF volume and sleep dysfunction, the glymphatic system could be dysregulated in infants who develop autism.